Mathematical modeling improves EC50 estimations from classical dose–response curves
暂无分享,去创建一个
Gunnar Cedersund | William Lövfors | Elin Nyman | Karin Lundengård | Ida Cervin | Jordi Altimiras | Theresia Arbring Sjöström | G. Cedersund | E. Nyman | J. Altimiras | I. Lindgren | William Lövfors | K. Lundengård | Ida Cervin | Isa Lindgren | Karin Lundengård | Elin Nyman
[1] David O. Holland,et al. Graphical Approach to Model Reduction for Nonlinear Biochemical Networks , 2011, PloS one.
[2] M. Jann,et al. Drug withdrawal syndromes-- a literature review. , 1980, The Western journal of medicine.
[3] Gunnar Cedersund,et al. Mechanistic explanations for counter‐intuitive phosphorylation dynamics of the insulin receptor and insulin receptor substrate‐1 in response to insulin in murine adipocytes , 2012, The FEBS journal.
[4] C. Rohlicek,et al. Effects of neonatal hypoxia in the rat on inotropic stimulation of the adult heart. , 2005, Cardiovascular research.
[5] Thomas C. Rich,et al. Roles of GRK and PDE4 Activities in the Regulation of β2 Adrenergic Signaling , 2008, The Journal of general physiology.
[6] Ursula Klingmüller,et al. Structural and practical identifiability analysis of partially observed dynamical models by exploiting the profile likelihood , 2009, Bioinform..
[7] J. Altimiras,et al. Chronic prenatal hypoxia sensitizes beta-adrenoceptors in the embryonic heart but causes postnatal desensitization. , 2009, American journal of physiology. Regulatory, integrative and comparative physiology.
[8] Gunnar Cedersund,et al. Mass and Information Feedbacks through Receptor Endocytosis Govern Insulin Signaling as Revealed Using a Parameter-free Modeling Framework* , 2010, The Journal of Biological Chemistry.
[9] M. Bruchez,et al. Detection and Quantification of β2AR Internalization in Living Cells Using FAP-Based Biosensor Technology , 2010, Journal of biomolecular screening.
[10] Jens Timmer,et al. Likelihood based observability analysis and confidence intervals for predictions of dynamic models , 2011, BMC Systems Biology.
[11] J. Altimiras,et al. CALL FOR PAPERS Fetal and Neonatal Programming: Epigenetic Modification of Phenotype Prenatal hypoxia programs changes in -adrenergic signaling and postnatal cardiac contractile dysfunction , 2013 .
[12] S. Green,et al. Beta 1- and beta 2-adrenergic receptors display subtype-selective coupling to Gs. , 1992, Molecular pharmacology.
[13] Edda Klipp,et al. Systems Biology , 1994 .
[14] R. Ahlquist,et al. A study of the adrenotropic receptors. , 1948, The American journal of physiology.
[15] Martin J. Lohse,et al. β2-Adrenergic Receptor Redistribution in Heart Failure Changes cAMP Compartmentation , 2010, Science.
[16] Marisa C Eisenberg,et al. Determining identifiable parameter combinations using subset profiling. , 2014, Mathematical biosciences.
[17] Jacob Roll,et al. Systems biology: model based evaluation and comparison of potential explanations for given biological data , 2009, The FEBS journal.
[18] H. Steven Wiley,et al. Receptor downregulation and desensitization enhance the information processing ability of signalling receptors , 2007, BMC Syst. Biol..
[19] R. Lefkowitz,et al. PKA-mediated phosphorylation of the beta1-adrenergic receptor promotes Gs/Gi switching. , 2004, Cellular signalling.
[20] Gunnar Cedersund,et al. Insulin Signaling in Type 2 Diabetes , 2013, The Journal of Biological Chemistry.
[21] Lili X. Peng,et al. Systems analysis of PKA-mediated phosphorylation gradients in live cardiac myocytes , 2006, Proceedings of the National Academy of Sciences.
[22] Gunnar Cedersund,et al. A Hierarchical Whole-body Modeling Approach Elucidates the Link between in Vitro Insulin Signaling and in Vivo Glucose Homeostasis* , 2011, The Journal of Biological Chemistry.
[23] A. McCulloch,et al. Modeling β-Adrenergic Control of Cardiac Myocyte Contractility in Silico* , 2003, Journal of Biological Chemistry.
[24] T. K. Harden,et al. High-affinity binding of agonists to beta-adrenergic receptors on intact cells. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[25] Robert J. Lefkowitz,et al. Seven-transmembrane-spanning receptors and heart function , 2002, Nature.
[26] J. Spertus,et al. A GRK5 polymorphism that inhibits β-adrenergic receptor signaling is protective in heart failure , 2008, Nature Medicine.
[27] Henning Schmidt. SBaddon: high performance simulation for the Systems Biology Toolbox for MATLAB , 2007, Bioinform..
[28] V. Bondarenko. A Compartmentalized Mathematical Model of the β1-Adrenergic Signaling System in Mouse Ventricular Myocytes , 2014, PloS one.
[29] B. Kobilka,et al. Beta-adrenergic receptor subtype-specific signaling in cardiac myocytes from beta(1) and beta(2) adrenoceptor knockout mice. , 2001, Molecular pharmacology.
[30] Andrew D McCulloch,et al. Mechanistic systems models of cell signaling networks: a case study of myocyte adrenergic regulation. , 2004, Progress in biophysics and molecular biology.
[31] T. Eschenhagen. β-adrenergic signaling in heart failure—adapt or die , 2008, Nature Medicine.
[32] Thomas C. Rich,et al. Roles of GRK and PDE4 Activities in the Regulation of b2 Adrenergic Signaling , 2008 .
[33] B. Kobilka,et al. β-Adrenergic Receptor Subtype-Specific Signaling in Cardiac Myocytes from β1 and β2 Adrenoceptor Knockout Mice , 2001 .
[34] Andrew D McCulloch,et al. Modeling beta-adrenergic control of cardiac myocyte contractility in silico. , 2003, The Journal of biological chemistry.
[35] Mats Jirstrand,et al. Systems biology Systems Biology Toolbox for MATLAB : a computational platform for research in systems biology , 2006 .
[36] T. Eschenhagen,et al. β-Adrenergic stimulation and myocardial function in the failing heart , 2009, Heart Failure Reviews.
[37] C. Sucharov. β-adrenergic pathways in human heart failure , 2007 .
[38] Gunnar Cedersund,et al. Conclusions via unique predictions obtained despite unidentifiability – new definitions and a general method , 2012, The FEBS journal.
[39] M. Fung,et al. Impaired Gsα and adenylyl cyclase cause β-adrenoceptor desensitization in chronically hypoxic rat hearts , 2000 .
[40] Y. Xiang,et al. Agonist Dose-dependent Phosphorylation by Protein Kinase A and G Protein-coupled Receptor Kinase Regulates β2 Adrenoceptor Coupling to Gi Proteins in Cardiomyocytes* , 2009, The Journal of Biological Chemistry.
[41] Harald Martens,et al. Global structure of sloppiness in a nonlinear model , 2014 .
[42] Necmettin Yildirim,et al. β2-Adrenergic Receptor Signaling and Desensitization Elucidated by Quantitative Modeling of Real Time cAMP Dynamics* , 2008, Journal of Biological Chemistry.
[43] M. Zheng,et al. The enigma of beta2-adrenergic receptor Gi signaling in the heart: the good, the bad, and the ugly. , 2005, Circulation research.
[44] Jason H. Yang,et al. Phospholemman is a negative feed-forward regulator of Ca2+ in β-adrenergic signaling, accelerating β-adrenergic inotropy. , 2012, Journal of molecular and cellular cardiology.
[45] J. Corbin,et al. Involvement of cAMP-dependent protein kinase in the regulation of heart contractile force. , 1977, The American journal of physiology.
[46] M. Zheng,et al. The Enigma of β2-Adrenergic Receptor Gi Signaling in the Heart: The Good, the Bad, and the Ugly , 2005 .